Pacific Biosciences Of California (PACB) FCF Margin (2010 - 2026)

Pacific Biosciences Of California's FCF Margin history runs 17 years deep, the most recent figure standing at 128.39% for Q1 2026.

• In Q1 2026, FCF Margin fell 607.0% year-over-year to 128.39%; the TTM figure through Mar 2026 stood at 72.62% (up 4430.0% YoY), while the FY2025 annual figure was 71.2%, up 6661.0% from the prior year.
• FCF Margin was 128.39% for Q1 2026 at Pacific Biosciences Of California, down from 44.64% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 44.64% in Q4 2025 to a low of 252.99% in Q1 2023.
• Historically, FCF Margin has averaged 142.22% across 5 years, with a median of 122.32% in 2025.
• The sharpest annual moves came in 2022 and 2023: FCF Margin plunged 16814 bps in 2022, then surged 13725 bps in 2023.
• A 5-year view of FCF Margin shows it stood at 239.35% in 2022, then surged by 57 bps to 102.1% in 2023, then increased by 19 bps to 82.26% in 2024, then jumped by 46 bps to 44.64% in 2025, then sank by 188 bps to 128.39% in 2026.
• The last three FCF Margin figures came in at 128.39% (Q1 2026), 44.64% (Q4 2025), and 48.44% (Q3 2025), per Business Quant data.